Drug Profile
Research programme: sphingosine 1 phosphate receptor 2 antagonists - Arroyo BioSsciences
Latest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator Arroyo BioSciences
- Class
- Mechanism of Action Sphingosine-1-phosphate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Fibrosis; Inflammation
Most Recent Events
- 05 Sep 2023 Discontinued - Preclinical for Fibrosis in USA (PO)
- 05 Sep 2023 Discontinued - Preclinical for Inflammation in USA (PO)
- 28 Aug 2020 No recent reports of development identified for preclinical development in Fibrosis in USA (PO)